<DOC>
	<DOCNO>NCT03089489</DOCNO>
	<brief_summary>PGD syndrome characterize alveolocapillary barrier structural functional alteration surfactant inactivation vascular permeability increase , cause lung edema , parenchymal infiltrate progressive hypoxemia . PGD may enhance lung donor . Inflammatory structural change may present lung organ recovery and/or organ preservation . The investigator aim identify surfactant protein , inflammatory structural change lung donor cold ischemia , biomarkers PGD lung recipient .</brief_summary>
	<brief_title>Lung PGD Biomarkers Organ Donors</brief_title>
	<detailed_description>Primary graft dysfunction ( PGD ) responsible high early mortality lung transplant patient . Rationale The evolution lung transplantation may complicate primary graft dysfunction ( PGD ) , form acute respiratory distress syndrome cause ischemia-reperfusion-related phenomenon . PGD occur 15-50 % case responsible significant increase mortality , duration assist ventilation length stay intensive care . It also important risk factor medium-term development acute long-term rejection , bronchiolitis obliterans syndrome ( BOS ) - chronic rejection - drastically reduce survival graft . Surfactant proteins comprise secretory protein Clara cell ( 16-kd Clara cell protein-CC16 ) surfactant protein -A ( SP-A ) , -B ( SP-B ) -D ( SP- D ) recognize marker permeability alveolocapillary barrier . Based finding , postulate gene expression CC16 , SP-A , -B D alter pulmonary biopsy perform donor patient develop primary graft dysfunction pulmonary transplantation compare performed donor patient free syndrome . This study could therefore complementary mean objective assessment lung quality prior transplantation . Aims Objectives 1 . Describe , organ donor , change expression Clara Cell Protein ( CC16 ) , surfactant-associated protein ( A , B D ) , pro- anti-inflammatory cytokine circulate blood lung tissue organ recovery . 2 . Describe biological structural change period cold ischemia . 3 . Establish correlation biomarkers organ donor occurrence acute graft dysfunction lung recipient . Material method Inclusion Criteria All lung organ donor patient refer network recipient include obtain inform consent . Data Collection In donor , record demographic data ( age , sex ) , history , cause death , blood gas measurement , chest x-ray protocol , blood biological parameter , duration brain death appropriate hot ischemia time appropriate protocol bacteriological analyzes . In recipient , record demographic data ( age , sex ) , indication transplantation , result right catheterization perform pre-transplantation , standard intraoperative data , immunosuppression , Blood gas , chest x-ray protocol , fill balance blood biological parameter 24 , 48 72h . The declamping time record . Patients automatically follow rest life . Iterative biopsy perform first year detect possible acute rejection . The data include study . Biological sample In donor , perfusion preservation solution , 18 cc peripheral blood take ( dry tube , 9 cc ) . 1 tube store -80 째 C. , centrifuge ( 15 minute , 10000 / min , 20 째 C. ) serum store -80 째 C. Immediately lung recovery , pulmonary biopsy ( 6 cm2 ) perform low lobe . A fragment immediately place liquid nitrogen store -80 째 C. A second fragment store formalin 24h store paraffin block . Before implantation , end preservation period , new lung biopsy perform low lobe . Biological analyzes Histological examination gradation Lung tissue fix formalin stain hematoxylin-eosin gradate lung lesion [ ( 1 ) neutrophil infiltration , ( 2 ) airway epithelial cell damage , ( 3 ) interstitial edema , ( 4 ) Hyaline membrane ( 5 ) hemorrhage ] . Inflammation , apoptosis Surfactant proteins O Tissue mRNA measurement : real time Quantification PCR ( RTQ-PCR ) O Tissue peptide measurement : Western Blot - ELISA - MILLIPLEX O Treatment blood sample analyze : ELISA - MILLIPLEX Protein inflammatory cytokine ( TNF-alpha , IL-6 , IL-8 , IL-1 , IL33 ) ( IL-10 ) , intercellular adhesion molecule ( ICAM-1 , VCAM-1 ) , apoptosis ( Bax , Bcl2 , Caspases ) Evaluation apoptosis : TUNEL - Immunohistochemistry</detailed_description>
	<mesh_term>Primary Graft Dysfunction</mesh_term>
	<criteria>All organ donor lung recipient reach criterion lung recovery transplantation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Primary graft dysfunction</keyword>
	<keyword>Lung transplantation</keyword>
	<keyword>Surfactant Protein</keyword>
	<keyword>inflammation</keyword>
</DOC>